Tuberculous and fungal peritonitis in patients undergoing continuous ambulatory peritoneal dialysis

Sing Leung Lui1, Tak Mao Chan, Kar Neng Lai

  • 1Department of Medicine, The University of Hong Kong, Tung Wah Hospital, Hong Kong SAR, PR China. sllui@hku.hk

Insights

Tuberculous and fungal peritonitis are uncommon complications in continuous ambulatory peritoneal dialysis (CAPD) patients. This article reviews their clinical features, diagnosis, and management.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Peritonitis is a serious complication for patients on continuous ambulatory peritoneal dialysis (CAPD).
  • While bacterial peritonitis is common, tuberculous and fungal infections represent less frequent but significant causes of peritonitis in CAPD patients.
  • These infections require specific diagnostic and management strategies.

Purpose of the Study:

  • To highlight the clinical features, diagnostic approaches, and treatment strategies for tuberculous and fungal peritonitis in CAPD patients.
  • To raise awareness among clinicians regarding these uncommon but important causes of peritonitis.
  • To provide a concise overview of current knowledge on managing these specific CAPD-related infections.

Main Methods:

  • Review of clinical case data and relevant literature.
  • Analysis of diagnostic methods including fluid analysis and microbiological cultures.
  • Evaluation of treatment outcomes for tuberculous and fungal peritonitis.

Main Results:

  • Tuberculous and fungal peritonitis present with varied clinical signs, often mimicking bacterial peritonitis.
  • Diagnosis can be challenging, requiring specific microbiological and biochemical tests.
  • Effective management involves appropriate anti-tuberculous or anti-fungal therapy, often combined with CAPD management adjustments.

Conclusions:

  • Tuberculous and fungal infections are critical differential diagnoses in CAPD peritonitis.
  • Prompt and accurate diagnosis is essential for effective treatment and patient outcomes.
  • Adherence to specific therapeutic regimens is crucial for managing these infections in CAPD patients.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...